Jonathan Constantine Garneau

Jonathan Garneau practices at UVA University Medical Center in Charlottesville, Virginia.

Jonathan Garneau's NPI, 1487073516, was assigned on April 16, 2014. Jonathan Garneau graduated from University of Chicago, Pritzker School of Medicine in 2014. Jonathan Garneau holds Virginia license 0101270394.

Jonathan Garneau's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Jonathan Garneau's primary practice is UVA University Medical Center in Charlottesville, Virginia. Jonathan Garneau is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Jonathan Garneau to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Garneau practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Jonathan Garneau's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Jonathan Garneau is licensed in Virginia.

CMS data shows 560 Medicare services from Jonathan Garneau across 12 procedure codes in 2024, for 209 Medicare patients. Medicare paid $45,661 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 209 Medicare patients who saw Jonathan Garneau in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Garneau's median patient age at 65, with 44% women.

In 2024, Jonathan Garneau wrote 34 Medicare Part D claims for 22 patients. 94% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $187 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Jonathan Garneau for performance year 2024, reported as part of a group. Jonathan Garneau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of melanoma (skin cancer) excision by Jonathan Garneau, more than 80% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Jonathan Garneau, published from 2014 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. Jonathan Garneau has published most often in Head Neck. Jonathan Garneau's most frequent co-authors are Brett A. Miles, DDS, MD, David C. Shonka, MD and Katherine L. Fedder, MD.

CMS Open Payments shows 12 general payments to Jonathan Garneau from 4 drug and device companies from 2019 to 2025. Education make up the largest share, 83% of the total. Intuitive Surgical, Inc. paid the most, $7,105.

Jonathan Garneau graduated from University of Chicago, Pritzker School of Medicine in 2014.